Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    0.00 (0.00%)
Bid:
806.00
Ask:
807.00
Spread: 1.00 (0.124%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Directorate Change

19 Sep 2018 09:34

RNS Number : 2513B
Savills PLC
19 September 2018
 

19 September 2018

SAVILLS PLC

SAVILLS ANNOUNCES NON-EXECUTIVE DIRECTOR CHANGES

Savills plc, the international real estate advisor, is pleased to announce the appointments of Stacey Cartwright and Florence Tondu-Melique as additional Independent Non-Executive Directors with effect from 1 October 2018.

Savills also announces that Charles McVeigh, who has served on the Board since 2000, will retire at the conclusion of the Company's AGM in May 2019.

Stacey Cartwright is currently the Senior Independent Director of the Football Association and was a non-executive director of GlaxoSmithKline plc from 2011 to 2016. Stacey is a chartered accountant and was previously Chief Executive (2014-17) and the Deputy Chairman (2017-18) of Harvey Nichols Group, before which she was Executive Vice President and CFO of Burberry Group plc (2004-13). Prior to 2004, Stacey was CFO of Egg plc having spent her early career with Granada Group plc.

Florence Tondu-Melique is currently Chief Executive of Zurich France and a member of Zurich's EMEA and Global Commercial Insurance Executive Committees. She was previously Chief Operating Officer of Hiscox Europe (2013-17), prior to which she was a Director at AXA Real Estate (2009-13) and AXA Investment Managers, which she joined in 2007. She spent her early career at McKinsey & Company.

There is no further information which would require disclosure under 9.6.13R of the Listing Rules of the UK Listing Authority in respect of either Stacey Cartwright or Florence Tondu-Melique.

Commenting on the changes, Nicholas Ferguson, Chairman of Savills plc said : "We are delighted that Stacey and Florence are joining the Board so that Savills can benefit from their extensive experience. I also want to thank Charlie McVeigh very warmly for his enormous contribution to the Board over so many years". 

For further information please contact:

Jeremy Helsby 020 7409 8934

Simon Shaw 020 7409 8934

David Allchurch /

Elizabeth Snow - Tulchan 020 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEAPNNFDDPEEF
Date   Source Headline
1st Jun 202611:29 amRNSTotal Voting Rights
22nd May 202610:09 amRNSDirector/PDMR Shareholding
14th May 202612:41 pmRNSResult of AGM
13th May 20264:16 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Statement
12th May 20263:41 pmRNSDirector/PDMR Shareholding
7th May 20263:39 pmRNSDirector Declaration
29th Apr 20263:04 pmRNSReplacement - Director/PDMR Shareholding
29th Apr 20261:23 pmRNSDirector/PDMR Shareholding
28th Apr 20261:58 pmRNSDirector/PDMR Shareholding
13th Apr 20265:24 pmRNSHolding(s) in Company
13th Apr 20262:10 pmRNSDirector/PDMR Shareholding
7th Apr 20264:03 pmRNSAnnual Report and AGM Notice
1st Apr 202610:00 amRNSTotal Voting Rights
31st Mar 202612:55 pmRNSDirector/PDMR Shareholding
26th Mar 20268:57 amRNSDirector/PDMR Shareholding
24th Mar 202611:02 amRNSDirector/PDMR Shareholding
23rd Mar 20269:27 amRNSDirector/PDMR Shareholding
18th Mar 20263:47 pmRNSDirector/PDMR Shareholding
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
13th Mar 20261:34 pmRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:08 amRNSFinal Results
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
5th Mar 20265:00 pmRNSHolding(s) in Company
2nd Mar 20269:11 amRNSTotal Voting Rights
25th Feb 202611:14 amRNSHolding(s) in Company
11th Feb 20264:07 pmRNSDirector/PDMR Shareholding
4th Feb 20265:29 pmRNSHolding(s) in Company
2nd Feb 20265:32 pmRNSTotal Voting Rights
19th Jan 20268:30 amRNSDirectorship change
15th Jan 20267:00 amRNSYear End Trading Update
13th Jan 20265:40 pmRNSDirector/PDMR Shareholding
13th Jan 202612:59 pmRNSHolding(s) in Company
2nd Jan 20263:00 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
1st Dec 20259:49 amRNSTotal Voting Rights
11th Nov 20254:58 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:32 pmRNSTotal Voting Rights
13th Oct 20251:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.